Cargando…

Changing R&D models in research-based pharmaceutical companies

New drugs serving unmet medical needs are one of the key value drivers of research-based pharmaceutical companies. The efficiency of research and development (R&D), defined as the successful approval and launch of new medicines (output) in the rate of the monetary investments required for R&...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schuhmacher, Alexander, Gassmann, Oliver, Hinder, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847363/ https://www.ncbi.nlm.nih.gov/pubmed/27118048 http://dx.doi.org/10.1186/s12967-016-0838-4

Ejemplares similares

Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?
por: Schuhmacher, Alexander, et al.
Publicado: (2018)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
por: Rasekh, Hamid Reza, et al.
Publicado: (2012)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models
por: Ferrara, Joseph
Publicado: (2007)

Regulation of Clinical Research Sponsored by Pharmaceutical Companies: A Proposal
por: Sotelo, Julio
Publicado: (2006)

R&D Implementation in a Department of Laboratory Medicine and Pathology: A Systematic Review Based on Pharmaceutical Companies
por: Feulefack, Joseph, et al.
Publicado: (2015)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

The Pharmaceutical Company Approach to Antibiotic Policies
por: White, Anthony R.
Publicado: (2005)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies—An Empirical Study Based on the Difference-in-Differences Model
por: Wei, Yanyi, et al.
Publicado: (2022)

A bi-level multi-follower optimization model for R&D project portfolio: an application to a pharmaceutical holding company
por: Salehi, Faraz, et al.
Publicado: (2022)

Error in Payments From Some Pharmaceutical Companies
Publicado: (2019)

Unmet Medical Needs and the Role of Pharmaceutical Companies
por: Meyer-Sabellek, Wolfgang
Publicado: (2009)

Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study
por: Parker, Lisa, et al.
Publicado: (2019)

Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan
por: Ichikawa, Iekuni, et al.
Publicado: (2016)

Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D
por: Flatau, Tina, et al.
Publicado: (2022)

Public Health and Political Corporate Social Responsibility: Pharmaceutical Company Engagement in COVAX
por: Scholz, Markus, et al.
Publicado: (2023)

Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
por: Smith, Richard
Publicado: (2005)

Ten Simple Rules for Internship in a Pharmaceutical Company
por: Chen, Bin
Publicado: (2014)

Pharmaceutical companies as the funding sources for continuing medical education
por: Kanchan, Tanuj
Publicado: (2015)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

The Contrasting Perceptions and the Cause Regarding Patenting Technologies Between Academic Medical Researchers and Pharmaceutical Companies Based in Japan
por: Sugimitsu, Kazunari, et al.
Publicado: (2021)

Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
por: Nagaich, Upendra, et al.
Publicado: (2015)

The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland
por: Heiskanen, Kati, et al.
Publicado: (2017)

The Internationalization Challenge: Where to Access Innovation
por: Gassmann, Oliver, et al.
Publicado: (2018)

Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis
por: Lexchin, Joel
Publicado: (2018)

Multinational Pharmaceutical Companies Shortchange Canada in Research and Development Investments: Is It Time to Pursue Other Options?
por: Lee, Shoo K., et al.
Publicado: (2023)

Transformative dynamism in pharmaceutical and biomedical research: Complexity of integration of innovative R & D hubs
por: Omidi, Yadollah, et al.
Publicado: (2021)

Managing robotics in the bioanalytical/metabolic environment of a pharmaceutical company
por: Kushinsky, Stanley
Publicado: (1991)

A survey of pharmaceutical company representative interactions with doctors in Libya
por: Alssageer, Mustafa A., et al.
Publicado: (2012)

The Effect of Capital Structure on the Profitability of Pharmaceutical Companies The Case of Iran
por: Mohammadzadeh, Mehdi, et al.
Publicado: (2013)

Pharmaceutical company perspectives on current safety risk communications in Japan
por: Urushihara, Hisashi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o65tksd6m1i7g72sm3ufp91thi